L3Harris (LHX) Q3 2026 Earnings Call Transcript

L3Harris reported Q3 revenue of $6.1 billion, up 7% year over year, with 9% organic growth despite one fewer week; EPS rose 33% to $3.28 and free cash flow increased 195% to $1.3 billion. Backlog reached $53.2 billion, up 47% year over year, including $11 billion in PAC-3 and THAAD awards, and management raised 2026 revenue guidance to $23.5–$23.7 billion and EPS guidance to $12.25–$12.35 while reaffirming $3 billion in free cash flow. The company lowered its 2028 free cash flow target to $3 billion from $3.5 billion and expects approximately 16% segment margins; management cited supply disruption affecting a small handful of components but said it had largely worked through the issue.

Analysis

LHX’s central re-rating question is no longer whether demand exists, but whether funded demand converts into on-time deliveries and acceptable returns. Large missile awards improve visibility, yet framework awards and multi-year backlog are not near-term revenue: appropriations, contract finalization, supplier throughput and factory qualification govern conversion. The $3B capacity build therefore creates a two-sided exposure—future volume leverage if utilization ramps, but execution, working-capital and fixed-price cost risk if bottlenecks persist. Watch delivery cadence and segment margins, not headline book-to-bill alone.

One second-order constraint is electronic components: PCB-laminate capacity competes with AI/data-center demand. Management expects the disruption to clear, but any recurrence could cap communications growth even as defense orders strengthen. Conversely, automation gains may improve throughput and margins, though one inspection-time example is not proof of enterprise-wide savings. Palantir’s cited collaboration is a potential efficiency channel, not evidence of material revenue contribution.

Near term, raised 2026 guidance and strong cash generation support sentiment, but quarterly FCF benefited from collection timing and the 2028 FCF reduction is not wholly operational deterioration: cash-funding retirement contributions avoids dilution, while earlier capex supports later capacity. Over 1–3 months, test the thesis against Q4 recovery in communications, missile deliveries and margin execution. Over 6–18 months, capacity ramp and the mid-2027 IPO decision are meaningful catalysts; IPO value depends on market pricing, not just backlog. The contrarian risk is treating backlog as guaranteed earnings: undefinitized awards, budget timing and fixed-price execution could disappoint. No valuation or peer-spread data supports a price target or aggressive pair trade.

Key Decisions for Investors

• Favor a measured LHX overweight rather than chasing backlog headlines; add on evidence of Q4 communications recovery and sustained missile delivery growth, while sizing for execution and appropriation risk.
• Track quarterly missile segment margins, delivery rates, capex versus plan, and cash conversion. Reduce exposure if capacity investment rises without improving throughput, or if guidance/backlog conversion weakens.
• Monitor PCB-laminate availability as a cross-sector bottleneck: renewed disruption would challenge LHX communications growth despite defense demand. Treat the reported resolution as management guidance pending subsequent results.
• Do not underwrite the mid-2027 Missile Solutions IPO as a base-case catalyst. Reassess only when valuation, retained ownership and contract economics are clearer; avoid inferring a PLTR earnings benefit from the operational partnership alone.